Conclusions: Risk of statin-associated elevated liver enzymes or rhabdomyolysis is not related to the magnitude of LDL-C lowering.

• 结论： 他汀类药物引起的肝酶升高或者横纹肌溶解症与LDL-C降低的幅度无关。